Literature DB >> 20717620

Investigating dynamics of inhibitory and feedback loops in ERK signalling using power-law models.

Julio Vera1, Oliver Rath, Eva Balsa-Canto, Julio R Banga, Walter Kolch, Olaf Wolkenhauer.   

Abstract

The investigation of the structure and dynamics of signal transduction systems through data-based mathematical models in ordinary differential equations or other paradigms has proven to be a successful approach in recent times. Extending this concept, we here analysed the use of kinetic models based on power-law terms with non-integer kinetic orders in the validation of hypotheses concerning regulatory structures in signalling systems. We integrated pre-existent biological knowledge, hypotheses and experimental quantitative data into a power-law model to validate the existence of certain regulatory loops in the Ras/Raf-1/MEK/ERK pathway, a MAPK pathway involved in the transduction of mitogenic and differentiation signals. Towards this end, samples of a human mammary epithelial cell line (MCF-10A) were used to obtain time-series data, characterising the behaviour of the system after epidermal growth factor stimulation in different scenarios of expression for the critical players of the system regarding the investigated loops (e.g., the inhibitory protein RKIP). The mathematical model was calibrated using a computational procedure that included: analysis of structural identifiability, global ranking of parameters to detect the most sensitivity ones towards the experimental setup, model calibration using global optimization methods to find the parameter values that better fit the data, and practical identifiability analysis to estimate the confidence in the estimated values for the parameters. The obtained model was used to perform computational simulations concerning the role of the investigated regulatory loops in the time response of the signalling pathway. Our findings suggest that the special regularity in the structure of the power-law terms make them suitable for a data-based validation of regulatory loops in signalling pathways. The model-based analysis performed identified RKIP as an actual inhibitor of the activation of the ERK pathway, but also suggested the existence of an intense feedback-loop control of the pathway by the activated ERK that maybe responsible for the damped oscillations we saw in the fraction of activated MEK both in the experiments and simulations. In addition, the model analysis suggested that phosphorylation/deactivation of RKIP during the transient stimulation may have a significant effect on the signalling peaks of both MEK and ERK. This later result suggests that dynamic modulation of signal inhibitors during stimulation may be a regulatory mechanism in ERK signalling and other pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20717620     DOI: 10.1039/c0mb00018c

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  5 in total

1.  Downregulation of Raf-1 kinase inhibitory protein as a sorafenib resistance mechanism in hepatocellular carcinoma cell lines.

Authors:  Jin Sun Kim; Gwang Hyeon Choi; Yusun Jung; Kang Mo Kim; Se-Jin Jang; Eun Sil Yu; Han Chu Lee
Journal:  J Cancer Res Clin Oncol       Date:  2018-06-01       Impact factor: 4.553

2.  AMIGO, a toolbox for advanced model identification in systems biology using global optimization.

Authors:  Eva Balsa-Canto; Julio R Banga
Journal:  Bioinformatics       Date:  2011-06-17       Impact factor: 6.937

3.  Minimal oscillating subnetwork in the Huang-Ferrell model of the MAPK cascade.

Authors:  Otto Hadač; František Muzika; Vladislav Nevoral; Michal Přibyl; Igor Schreiber
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

4.  Computational analysis of target hub gene repression regulated by multiple and cooperative miRNAs.

Authors:  Xin Lai; Ulf Schmitz; Shailendra K Gupta; Animesh Bhattacharya; Manfred Kunz; Olaf Wolkenhauer; Julio Vera
Journal:  Nucleic Acids Res       Date:  2012-07-13       Impact factor: 16.971

5.  Model-based genotype-phenotype mapping used to investigate gene signatures of immune sensitivity and resistance in melanoma micrometastasis.

Authors:  Guido Santos; Svetoslav Nikolov; Xin Lai; Martin Eberhardt; Florian S Dreyer; Sushmita Paul; Gerold Schuler; Julio Vera
Journal:  Sci Rep       Date:  2016-04-26       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.